title: [Metabolic fingerprinting of blood plasma for patients with prostate cancer].
abstract: Application of blood plasma metabolites fingerprinting for the diagnostic of the 2nd stage of prostate cancer has been investigated. The diagnostic sensitivity (95%), specificity (96.7%) and accuracy (95.7%) of the metabolic fingerprinting were much higher then those for PSA test (35%, 83.3% and 51.7%, respectively) for the same patients. Area under the ROC-curve (0.994) suggests that the proposed approach is effective and can be used for clinical applications.
authors: P G
authors: PG
authors: Lokhov
authors: M I
authors: MI
authors: Dashtiev
authors: L V
authors: LV
authors: Bondartsov
authors: A V
authors: AV
authors: Lisitsa
authors: S A
authors: SA
authors: Moshkovskiĭ
authors: A I
authors: AI
authors: Archakov
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D001798:Blood Proteins / Q000032:analysis*; D006801:Humans; D008297:Male; D055442:Metabolome; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis; D012372:ROC Curve; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D014408:Biomarkers, Tumor; D001798:Blood Proteins